Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107353221A details a novel Pd-catalyzed synthesis for high-purity chiral intermediates. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN101569864B details a novel chiral sulfonamide catalyst enabling high-yield asymmetric conjugate addition, offering a metal-free alternative for pharmaceutical manufacturing.
Novel organocatalyst for asymmetric hydroamination. Reduces transition metal dependency. High enantioselectivity for chiral piperidine synthesis.
Patent CN111285768B introduces a recyclable polyionic liquid copper catalyst for efficient asymmetric Henry reactions in water, offering significant cost reduction in chiral catalyst manufacturing.
Patent CN117105887A reveals a novel Salen Co-catalyzed resolution for chiral epichlorohydrin. Achieve high purity, catalyst recycling, and significant cost reduction in pharmaceutical manufacturing.
Patent CN102329281A details a novel asymmetric Steglich rearrangement for C-acyl azlactones, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Novel axial and central chirality catalyst enables high enantioselectivity. Reduces costs in pharmaceutical intermediates manufacturing with scalable synthesis.
Novel semipinacol rearrangement route for high-purity chiral spiro ketones. Efficient scale-up for pharma intermediates and catalyst ligands.
Patent CN107721969B reveals a safe, high-yield route for chiral TADDOLs using isopropyl magnesium bromide, offering significant cost reduction and supply chain reliability.
Patent CN101270112A details a polymeric Schiff base-metal complex for high-ee cyclic carbonates, offering superior recyclability and cost efficiency for pharma intermediates.
Patent CN104119352B reveals manganese-catalyzed asymmetric epoxidation. Delivers high purity chiral epoxides with reduced waste and scalable supply chain reliability for global pharmaceutical intermediates.
Novel iron-catalyzed asymmetric hydrogenation using chiral quinoline imidazoline ligands offers high enantioselectivity and cost-effective alternatives to noble metals for pharmaceutical intermediates.
Patent CN110845547A details novel Pd-catalyzed asymmetric alkylation. Offers high ee values and mild conditions for indole derivatives manufacturing.
Patent CN111285769B details a polyionic liquid copper catalyst for efficient, green aqueous Henry reactions, offering high enantioselectivity and simplified supply chains for pharmaceutical intermediates.
Novel FeCl3-catalyzed oxidative coupling for 3,3'-diindoles. High purity, scalable process for API intermediates. Cost-effective manufacturing solution.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Patent CN112824374B details a nickel-catalyzed asymmetric hydrogenation method for chiral amines, offering cost-effective alternatives to precious metals for pharmaceutical intermediates.
Novel heterogeneous copper catalyst enables high yield chiral synthesis for pharmaceutical intermediates supply chain optimization and significant cost reduction capabilities for global buyers.
Patent CN117720467A reveals a novel 4-step route for chiral catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.